Clinical Trial Update: Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the fixed-dose combination aliskiren/hydrochlorothiazide to amlodipine in patients with Stage 2 systolic hypertension and diabetes; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertension

Drugs mentioned

• Aliskiren/hydrochlorothiazide (aliskiren/hydrochlorothiazide)
• Amlodipine (amlodipine)

Snippet

Sponsor: Novartis | Conditions: Hypertension, Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2011-05-23